A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhibitors Tablets in the United Kingdom - Trial NCT05555979
Access comprehensive clinical trial information for NCT05555979 through Pure Global AI's free database. This phase not specified trial is sponsored by AbbVie and is currently Not yet recruiting. The study focuses on Chronic Lymphocytic Leukemia. Target enrollment is 140 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
AbbVie
Timeline & Enrollment
N/A
Sep 30, 2022
Jul 31, 2023
Primary Outcome
Number of Participants with a Change in Chronic Lymphocytic Leukemia (CLL) Symptoms
Summary
Chronic lymphocytic leukemia (CLL), a form of Non-Hodgkin's Lymphoma, is the most common type
 of leukemia in adults, affecting approximately 3,800 people in the UK each year. This study
 will evaluate the patient experience of CLL in adult participants who are prescribed
 venetoclax+rituximab or Bruton's tyrosine kinase inhibitors in the United Kingdom (UK).
 
 Venetoclax+rituximab is a drug approved to treat CLL. Study participants will receive
 venetoclax+rituximab as prescribed by their study doctor in accordance with approved local
 label. Adult participants prescribed venetoclax+rituximab or Bruton's tyrosine kinase
 inhibitors will be enrolled. Around 140 participants will be enrolled in the study in
 approximately 10 sites in the UK.
 
 Participants will receive venetoclax tablets to be taken by mouth and rituximab intravenous
 (IV) injection according to the approved local label.
 
 There is expected to be no additional burden for participants in this trial. All study visits
 will occur during routine clinical practice.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05555979
Non-Device Trial